WIGRAINE Drug Patent Profile
When do Wigraine patents expire, and what generic alternatives are available?
Wigraine is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in WIGRAINE is caffeine; ergotamine tartrate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for WIGRAINE?
- What are the global sales for WIGRAINE?
- What is Average Wholesale Price for WIGRAINE?
Summary for WIGRAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Clinical Trials: | 1 |
| DailyMed Link: | WIGRAINE at DailyMed |
Recent Clinical Trials for WIGRAINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stanford University | Phase 2 |
US Patents and Regulatory Information for WIGRAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | WIGRAINE | caffeine; ergotamine tartrate | TABLET;ORAL | 086562-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
